Cargando…
Efficiency of Cytology Samples for PD-L1 Evaluation and Comparison with Tissue Samples
Objective: Lung cancer is the leading cause of cancer-related death. PD-L1 blockers have become a first-line option for advanced non-small cell lung cancer (NSCLC) patients. Guidelines require the assessment of PD-L1 expression by immunohistochemistry. Although tissue samples are widely used, cytolo...
Autores principales: | Kulaç, İbrahim, Aydın, Aslı, Bulutay, Pınar, Fırat, Pınar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Federation of Turkish Pathology Societies
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510593/ https://www.ncbi.nlm.nih.gov/pubmed/32692398 http://dx.doi.org/10.5146/tjpath.2020.01494 |
Ejemplares similares
-
The importance of histological patterns on PD-L1 staining heterogeneity: Should we use pattern-based approach for selecting tumor samples for PD-L1 testing in lung adenocarcinomas?
por: BULUTAY, Pınar, et al.
Publicado: (2021) -
What Would Next Generation Sequencing Bring to the Diagnosis and Treatment of Sarcomas? A Series of 20 Cases, a Single Institution’s Experience
por: Kulaç, İbrahim, et al.
Publicado: (2021) -
Comparison of PD-L1, EGFR, ALK, and ROS1 Status Between Surgical Samples and Cytological Samples in Non-Small Cell Lung Carcinoma
por: Ekin, Zübeyde, et al.
Publicado: (2021) -
PD-L1 in Cytological Samples: A Review and a Practical Approach
por: Tejerina, Eva, et al.
Publicado: (2021) -
Clear cell carcinoma of the uterine cervix; an unusual HPV-independent tumor: Clinicopathological features, PD-L1 expression, and mismatch repair protein deficiency status of 16 cases
por: Bulutay, Pınar, et al.
Publicado: (2023)